These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17059436)

  • 1. Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine.
    Gupta S; Akerman S; van den Maagdenberg AM; Saxena PR; Goadsby PJ; van den Brink AM
    Cephalalgia; 2006 Nov; 26(11):1294-303. PubMed ID: 17059436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
    Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
    Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
    Akerman S; Goadsby PJ
    Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation.
    Akerman S; Kaube H; Goadsby PJ
    Br J Pharmacol; 2003 Oct; 140(4):718-24. PubMed ID: 14534154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies.
    Williamson DJ; Hargreaves RJ; Hill RG; Shepheard SL
    Cephalalgia; 1997 Jun; 17(4):525-31. PubMed ID: 9209774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin.
    Gupta S; Villalón CM; Mehrotra S; de Vries R; Garrelds IM; Saxena PR; MaassenVanDenbrink A
    Headache; 2007 Feb; 47(2):225-35. PubMed ID: 17300362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
    Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
    Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
    Williamson DJ; Shepheard SL; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1997 Jun; 328(1):61-4. PubMed ID: 9203569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat.
    Petersen KA; Birk S; Doods H; Edvinsson L; Olesen J
    Br J Pharmacol; 2004 Nov; 143(6):697-704. PubMed ID: 15504760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
    Holland PR; Akerman S; Goadsby PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system.
    Labastida-Ramírez A; Rubio-Beltrán E; Haanes KA; Chan KY; Garrelds IM; Johnson KW; Danser AHJ; Villalón CM; MaassenVanDenBrink A
    Pain; 2020 May; 161(5):1092-1099. PubMed ID: 31977930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery.
    Bhatt DK; Ploug KB; Ramachandran R; Olesen J; Gupta S
    Headache; 2010 Jun; 50(6):1017-30. PubMed ID: 20487037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model.
    Chan KY; Gupta S; de Vries R; Danser AH; Villalón CM; Muñoz-Islas E; Maassenvandenbrink A
    Br J Pharmacol; 2010 Jul; 160(6):1316-25. PubMed ID: 20590623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice.
    Chan KY; Labastida-Ramírez A; Ramírez-Rosas MB; Labruijere S; Garrelds IM; Danser AH; van den Maagdenberg AM; MaassenVanDenBrink A
    J Cereb Blood Flow Metab; 2019 Apr; 39(4):718-729. PubMed ID: 28792272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
    Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
    Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.
    Akerman S; Williamson DJ; Goadsby PJ
    Br J Pharmacol; 2003 Oct; 140(3):558-66. PubMed ID: 12970082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
    Muñoz-Islas E; Gupta S; Jiménez-Mena LR; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
    Br J Pharmacol; 2006 Sep; 149(1):82-91. PubMed ID: 16880765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow.
    Tröltzsch M; Denekas T; Messlinger K
    Eur J Pharmacol; 2007 May; 562(1-2):103-10. PubMed ID: 17349622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception.
    Akerman S; Kaube H; Goadsby PJ
    J Pharmacol Exp Ther; 2004 Apr; 309(1):56-63. PubMed ID: 14718591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.